Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton's jelly.

Yoon JH, Roh EY, Shin S, Jung NH, Song EY, Chang JY, Kim BJ, Jeon HW.

Biomed Res Int. 2013;2013:428726. doi: 10.1155/2013/428726.

2.

Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.

Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S.

Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1.

PMID:
24532125
3.

Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.

Seo MS, Park SB, Kang KS.

Cell Transplant. 2012;21(7):1493-502.

PMID:
22732242
4.

Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.

Cell Tissue Res. 2011 Oct;346(1):53-64. doi: 10.1007/s00441-011-1249-8.

PMID:
21987220
5.

Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.

Margossian T, Reppel L, Makdissy N, Stoltz JF, Bensoussan D, Huselstein C.

Biomed Mater Eng. 2012;22(4):243-54. doi: 10.3233/BME-2012-0714.

PMID:
22785368
6.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957.

PMID:
21696238
7.

Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.

Xu Y, Huang S, Ma K, Fu X, Han W, Sheng Z.

J Tissue Eng Regen Med. 2012 Aug;6(8):645-54. doi: 10.1002/term.468.

PMID:
21916019
8.

Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.

He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.

Tissue Eng Part A. 2014 Apr;20(7-8):1314-24. doi: 10.1089/ten.TEA.2013.0333.

PMID:
24279891
9.

Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.

Amiri F, Halabian R, Dehgan Harati M, Bahadori M, Mehdipour A, Mohammadi Roushandeh A, Habibi Roudkenar M.

Hematology. 2015 May;20(4):208-16. doi: 10.1179/1607845414Y.0000000185.

PMID:
25116042
10.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010.

11.

Molecular pathways reflecting poor intrauterine growth are found in Wharton's jelly-derived mesenchymal stem cells.

Sukarieh R, Joseph R, Leow SC, Li Y, Löffler M, Aris IM, Tan JH, Teh AL, Chen L, Holbrook JD, Ng KL, Lee YS, Chong YS, Summers SA, Gluckman PD, Stünkel W.

Hum Reprod. 2014 Oct 10;29(10):2287-301. doi: 10.1093/humrep/deu209.

PMID:
25129543
12.

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.

Regen Med. 2014;9(6):723-32. doi: 10.2217/rme.14.60.

PMID:
25431909
13.

Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.

Hendijani F, Javanmard SH, Sadeghi-aliabadi H.

Tissue Cell. 2015 Jun;47(3):229-34. doi: 10.1016/j.tice.2015.01.005.

PMID:
25779671
14.

Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways.

Hao H, Chen G, Liu J, Ti D, Zhao Y, Xu S, Fu X, Han W.

PLoS One. 2013;8(3):e58314. doi: 10.1371/journal.pone.0058314.

15.

Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jelly.

Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Djordjević IO, Santibanez JF, Jovcić G, Terzić M, Bugarski D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86.

16.

A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures.

Julavijitphong S, Wichitwiengrat S, Tirawanchai N, Ruangvutilert P, Vantanasiri C, Phermthai T.

Cytotherapy. 2014 May;16(5):683-91. doi: 10.1016/j.jcyt.2013.07.012.

PMID:
24119645
17.

Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow.

Balasubramanian S, Thej C, Venugopal P, Priya N, Zakaria Z, Sundarraj S, Majumdar AS.

Cell Biol Int. 2013 May;37(5):507-15. doi: 10.1002/cbin.10056.

PMID:
23418097
18.

Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly.

Chen G, Yue A, Ruan Z, Yin Y, Wang R, Ren Y, Zhu L.

Stem Cell Res Ther. 2015 Nov 25;6:228. doi: 10.1186/s13287-015-0219-6.

19.

In Vitro Generation of IL-35-expressing Human Wharton's Jelly-derived Mesenchymal Stem Cells Using Lentiviral Vector.

Amari A, Ebtekar M, Moazzeni SM, Soleimani M, Mohammadi Amirabad L, Tahoori MT, Massumi M.

Iran J Allergy Asthma Immunol. 2015 Aug;14(4):416-26.

20.

Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS, Torshizi Z, Nematollahi-Mahani SN.

In Vitro Cell Dev Biol Anim. 2012 Feb;48(2):75-83. doi: 10.1007/s11626-011-9480-x.

PMID:
22274909

Supplemental Content

Support Center